Last updated: April 16, 2023
Sponsor: Sun Yat-sen University
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT05110040
TAOIMTIMAGE
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Informed consent
- Age 18-70 years old
- Diagnosed with TAO.
Exclusion
Exclusion Criteria:
- Contraindications to immunosuppressive agents.
- Patients with HIV, Hepatitis B or C, Tuberculosis or other active significantinfection.
- Patients with severe chronic diseases in heart, lung, kidney and liver, which make itnot tolerant to immunosuppressive agents.
- Patients have contraindications of MRI(metal pacemaker, fake teeth, foreign body andother materials which will disturb the examination).
Study Design
Total Participants: 12
Study Start date:
October 15, 2021
Estimated Completion Date:
December 01, 2025
Study Description
Connect with a study center
Zhongshan Ophthalmic Center
Guangzhou, Guangdong
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.